Developing AI to help clinicians detect polyps during colonoscopy
Small, flat precancerous lesions can be difficult to detect during colonoscopy. Limited training datasets also make these subtle abnormalities challenging for AI models, creating a need for tools that help clinicians identify early signs of colorectal cancer.
Ameretat is developing AI to detect polyps during colonoscopy and support clinicians during examinations. Its medical video technology is designed to analyse images on-site, reducing reliance on cloud infrastructure.
What stands out about Ameretat
Received investment from Future Tech Ventures alongside imec.istart; the financing amount was not disclosed.
Founded in 2025 as a spin-off from University Medical Center Groningen, building on Setareh Rezaee's doctoral research.
Founder Setareh Rezaee developed the underlying medical-imaging AI through doctoral research at UMCG.
Co-founder and COO Gijs Schumer describes himself as a three-time founder, mainly in MedTech.
Signed a licensing agreement with UMCG to commercialise AI-driven medical video analysis technology originating from UMCG research.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.